- 肝細胞性の、肝細胞の
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 原発性肝細胞癌の臨床的特徴および診断 clinical features and diagnosis of primary hepatocellular carcinoma
- 2. 進行性肝細胞癌に対する全身治療 systemic treatment for advanced hepatocellular carcinoma
- 3. 肝細胞癌に対する治療法の概要 overview of treatment approaches for hepatocellular carcinoma
- 4. 切除可能な肝細胞癌のマネージメント：予後、術前補助化学療法と補助化学療法の役割、
および治療後サーベイランス management of potentially resectable hepatocellular carcinoma prognosis role of neoadjuvant and adjuvant therapy and posttreatment surveillance - 5. 肝細胞癌における病期分類および予後因子 staging and prognostic factors in hepatocellular carcinoma
English Journal
- Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients.
- Lim TS1, Kim do Y1, Han KH1, Kim HS2, Shin SH1, Jung KS1, Kim BK1, Kim SU1, Park JY1, Ahn SH1.
- Scandinavian journal of gastroenterology.Scand J Gastroenterol.2016 Mar;51(3):344-53. doi: 10.3109/00365521.2015.1082190. Epub 2015 Sep 4.
- OBJECTIVE: As data on the effectiveness of tumor markers in detecting hepatocellular carcinoma (HCC) in cirrhotic patients are limited, we investigated the diagnostic accuracy of alpha-fetoprotein (AFP), protein induced by vitamin K absence or antagonist-II (PIVKA-II), and Lens culinaris agglutinin-
- PMID 26340708
- Systematic Review and Meta-Analysis: Circulating miRNAs for Diagnosis of Hepatocellular Carcinoma.
- Huang JT1, Liu SM1, Ma H2, Yang Y1, Zhang X3, Sun H2, Zhang X3, Xu J3, Wang J3,4.
- Journal of cellular physiology.J Cell Physiol.2016 Feb;231(2):328-35. doi: 10.1002/jcp.25135. Epub 2015 Sep 9.
- Because early-stage hepatocellular carcinoma (HCC) is difficult to diagnose using the existing techniques, identifying better biomarkers would likely improve the patients' prognoses. We performed a systematic review and meta-analysis of published studies to appraise the utility of microRNAs (miRNAs)
- PMID 26291451
- Impact of portal hemodynamics on Doppler ultrasonography for predicting decompensation and long-term outcomes in patients with cirrhosis.
- Kondo T1, Maruyama H1, Sekimoto T1, Shimada T1, Takahashi M1, Okugawa H1, Yokosuka O1.
- Scandinavian journal of gastroenterology.Scand J Gastroenterol.2016 Feb;51(2):236-44. doi: 10.3109/00365521.2015.1081275. Epub 2015 Sep 10.
- OBJECTIVE: Significance of portal hemodynamics for non-invasive marker of cirrhosis remains unclear. The aim was to determine the value of portal hemodynamics on Doppler ultrasound for predicting decompensation and prognosis in cirrhosis.METHODS: This retrospective study comprised 236 cirrhotic pati
- PMID 26357874
Japanese Journal
- 肝細胞癌肝切除後の合併症対策 : 危険因子に関する検討 (特集 消化器外科術後合併症の治療)
- 石崎 守彦,海堀 昌樹,松井 康輔 [他]
- 外科 = Surgey : 臨床雑誌 76(1), 47-51, 2014-01
- NAID 40019926326
- The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma
- Zeng Sha Sha,Yamashita Taro,Kondo Mitsumasa,Nio Kouki,Hayashi Takehiro,Hara Yasumasa,Nomura Yoshimoto,Yoshida Mariko,Hayashi Tomoyuki,Oishi Naoki,Ikeda Hiroko,Honda Masao,Kaneko Shuichi
- Journal of Hepatology 60(1), 127-134, 2014-01
- … Aims: Recent evidence suggests that hepatocellular carcinoma can be classified into certain molecular subtypes with distinct prognoses based on the stem/maturational status of the tumor. … We investigated the transcription program deregulated in hepatocellular carcinomas with stem cell features. … Methods: Gene and protein expression profiles were obtained from 238 (analyzed by microarray), 144 (analyzed by immunohistochemistry), and 61 (analyzed by qRT-PCR) hepatocellular carcinoma cases. …
- NAID 120005349158
- 化学療法下にある末期肝細胞癌患者の亜鉛欠乏
- 本間 和宏,和田 安代,榎本 真理,小尾 俊太郎,若菜 宣明,田中 越郎
- 東京農業大学農学集報 58(3), 194-198, 2013-12-16
- 末期肝細胞癌患者では栄養状態の悪化が多く見られ,これは予後を左右する重要な因子である。化学療法目的で入院した 33名の IV 期肝細胞癌患者で,食事摂取状況と臨床検査データとの関連を調べた。血清中の直接ビリルビン,間接ビリルビン,LDH, AST, ALT, ALP, アルブミン,CRP, AFP さらに入院中の平均食事摂取率,食事摂取量,摂取エネルギー量,摂取食塩相当量,鉄摂取量,亜鉛摂取量,ビ …
- NAID 110009658771
Related Links
- Hepatocellular carcinoma accounts for most liver cancers. This type of cancer occurs more often in men than women. It is usually diagnosed in people age 50 or older. Hepatocellular carcinoma is not the same as metastatic liver cancer ...
- Hepatocellular carcinoma (HCC) represents approximately 90% of all cases of primary liver cancer. The main risk factors for developing HCC are well known and include hepatitis B and C virus infection, alcohol intake and ingestion of ...
Related Pictures
★リンクテーブル★
| リンク元 | 「liver cell」「hepatic parenchymal cell」「hepatocytic」「hepatic cell」「肝細胞性」 |
| 拡張検索 | 「hepatocellular damage」「hepatocellular injury」 |
「liver cell」
「hepatic parenchymal cell」
「hepatocytic」
- 肝細胞の
「hepatic cell」
「肝細胞性」
- 英
- hepatocellular
- 関
- 肝細胞